Kyle Mikson

Stock Analyst at Canaccord Genuity

(0)
# 4867
Out of 5,218 analysts
75
Total ratings
17.02%
Success rate
-28.34%
Average return
21 Stocks
Name Action Price Target Current % Upside Ratings Updated
Akoya Biosciences
Maintains: Buy
6 4
2.27 54.19% 3 Nov 15, 2024
Lucid Diagnostics
Maintains: Buy
3 3
0.78 284.62% 4 Nov 14, 2024
Quantum-Si
Maintains: Hold
2 1
1.73 -42.2% 3 Nov 13, 2024
Natera
Maintains: Strong Buy
150 165
166.11 -0.67% 5 Nov 13, 2024
Exact Sciences
Maintains: Buy
95 75
61.38 22.19% 9 Nov 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
130 145
143.9 0.76% 6 Nov 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
35 42
28.83 45.68% 3 Oct 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
32 20
14.18 41.04% 6 Oct 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
4 3
1.96 53.06% 7 Aug 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
3 5
0.36 1288.89% 3 Jul 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
30 38
34.67 9.6% 4 Jun 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
32 25
10.69 133.86% 4 Apr 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
26
n/a n/a 2 Mar 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
4
1.35 159.26% 2 Mar 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
5 2
n/a n/a 4 Nov 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
3
n/a n/a 4 Sep 25, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
3 2
0.57 250.88% 2 Aug 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
8 7
5.8 20.69% 1 Nov 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
50
0.76 6373.68% 1 Mar 30, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
19
1.94 879.38% 1 Jan 29, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
150
0.74 20170.27% 1 Jan 29, 2021